RNXT: RenovoRx, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 32.62
Enterprise Value ($M) 23.06
Book Value ($M) 7.07
Book Value / Share 0.29
Price / Book 4.61
NCAV ($M) 7.07
NCAV / Share 0.29
Price / NCAV 4.61

Profitability (mra)
Return on Invested Capital (ROIC) -1.30
Return on Assets (ROA) -6.25
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 5.66
Current Ratio 5.66

Balance Sheet (mrq) ($M)
Current Assets 10.03
Assets 10.03
Liabilities 2.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-08-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-04 10,555 56,382 18.72
2025-02-03 7,640 31,050 24.61
2025-01-31 6,965 38,053 18.30
2025-01-30 8,574 26,764 32.04

(click for more detail)

Similar Companies
RMTI – Rockwell Medical, Inc. RNAZ – TransCode Therapeutics, Inc.
RNTX – Rein Therapeutics Inc. RVPH – Reviva Pharmaceuticals Holdings, Inc.
RZLT – Rezolute, Inc.


Financial data and stock pages provided by
Fintel.io